A Long-Read Sequencing Approach for Direct Haplotype Phasing in Clinical Settings

The reconstruction of individual haplotypes can facilitate the interpretation of disease risks; however, high costs and technical challenges still hinder their assessment in clinical settings. Second-generation sequencing is the gold standard for variant discovery but, due to the production of short...

Full description

Bibliographic Details
Main Authors: Simone Maestri, Maria Giovanna Maturo, Emanuela Cosentino, Luca Marcolungo, Barbara Iadarola, Elisabetta Fortunati, Marzia Rossato, Massimo Delledonne
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/23/9177
_version_ 1797546027694161920
author Simone Maestri
Maria Giovanna Maturo
Emanuela Cosentino
Luca Marcolungo
Barbara Iadarola
Elisabetta Fortunati
Marzia Rossato
Massimo Delledonne
author_facet Simone Maestri
Maria Giovanna Maturo
Emanuela Cosentino
Luca Marcolungo
Barbara Iadarola
Elisabetta Fortunati
Marzia Rossato
Massimo Delledonne
author_sort Simone Maestri
collection DOAJ
description The reconstruction of individual haplotypes can facilitate the interpretation of disease risks; however, high costs and technical challenges still hinder their assessment in clinical settings. Second-generation sequencing is the gold standard for variant discovery but, due to the production of short reads covering small genomic regions, allows only indirect haplotyping based on statistical methods. In contrast, third-generation methods such as the nanopore sequencing platform developed by Oxford Nanopore Technologies (ONT) generate long reads that can be used for direct haplotyping, with fewer drawbacks. However, robust standards for variant phasing in ONT-based target resequencing efforts are not yet available. In this study, we presented a streamlined proof-of-concept workflow for variant calling and phasing based on ONT data in a clinically relevant 12-kb region of the <i>APOE</i> locus, a hotspot for variants and haplotypes associated with aging-related diseases and longevity. Starting with sequencing data from simple amplicons of the target locus, we demonstrated that ONT data allow for reliable single-nucleotide variant (SNV) calling and phasing from as little as 60 reads, although the recognition of indels is less efficient. Even so, we identified the best combination of ONT read sets (600) and software (BWA/Minimap2 and HapCUT2) that enables full haplotype reconstruction when both SNVs and indels have been identified previously using a highly-accurate sequencing platform. In conclusion, we established a rapid and inexpensive workflow for variant phasing based on ONT long reads. This allowed for the analysis of multiple samples in parallel and can easily be implemented in routine clinical practice, including diagnostic testing.
first_indexed 2024-03-10T14:24:15Z
format Article
id doaj.art-624d9da92bd24abbb69b9123fcaf52bb
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T14:24:15Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-624d9da92bd24abbb69b9123fcaf52bb2023-11-20T23:09:45ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-12-012123917710.3390/ijms21239177A Long-Read Sequencing Approach for Direct Haplotype Phasing in Clinical SettingsSimone Maestri0Maria Giovanna Maturo1Emanuela Cosentino2Luca Marcolungo3Barbara Iadarola4Elisabetta Fortunati5Marzia Rossato6Massimo Delledonne7Department of Biotechnology, University of Verona, 37134 Verona, ItalyDepartment of Biotechnology, University of Verona, 37134 Verona, ItalyDepartment of Biotechnology, University of Verona, 37134 Verona, ItalyDepartment of Biotechnology, University of Verona, 37134 Verona, ItalyDepartment of Biotechnology, University of Verona, 37134 Verona, ItalyDepartment of Biotechnology, University of Verona, 37134 Verona, ItalyDepartment of Biotechnology, University of Verona, 37134 Verona, ItalyDepartment of Biotechnology, University of Verona, 37134 Verona, ItalyThe reconstruction of individual haplotypes can facilitate the interpretation of disease risks; however, high costs and technical challenges still hinder their assessment in clinical settings. Second-generation sequencing is the gold standard for variant discovery but, due to the production of short reads covering small genomic regions, allows only indirect haplotyping based on statistical methods. In contrast, third-generation methods such as the nanopore sequencing platform developed by Oxford Nanopore Technologies (ONT) generate long reads that can be used for direct haplotyping, with fewer drawbacks. However, robust standards for variant phasing in ONT-based target resequencing efforts are not yet available. In this study, we presented a streamlined proof-of-concept workflow for variant calling and phasing based on ONT data in a clinically relevant 12-kb region of the <i>APOE</i> locus, a hotspot for variants and haplotypes associated with aging-related diseases and longevity. Starting with sequencing data from simple amplicons of the target locus, we demonstrated that ONT data allow for reliable single-nucleotide variant (SNV) calling and phasing from as little as 60 reads, although the recognition of indels is less efficient. Even so, we identified the best combination of ONT read sets (600) and software (BWA/Minimap2 and HapCUT2) that enables full haplotype reconstruction when both SNVs and indels have been identified previously using a highly-accurate sequencing platform. In conclusion, we established a rapid and inexpensive workflow for variant phasing based on ONT long reads. This allowed for the analysis of multiple samples in parallel and can easily be implemented in routine clinical practice, including diagnostic testing.https://www.mdpi.com/1422-0067/21/23/9177nanopore sequencingvariant callinghaplotype phasingdiagnostic testing
spellingShingle Simone Maestri
Maria Giovanna Maturo
Emanuela Cosentino
Luca Marcolungo
Barbara Iadarola
Elisabetta Fortunati
Marzia Rossato
Massimo Delledonne
A Long-Read Sequencing Approach for Direct Haplotype Phasing in Clinical Settings
International Journal of Molecular Sciences
nanopore sequencing
variant calling
haplotype phasing
diagnostic testing
title A Long-Read Sequencing Approach for Direct Haplotype Phasing in Clinical Settings
title_full A Long-Read Sequencing Approach for Direct Haplotype Phasing in Clinical Settings
title_fullStr A Long-Read Sequencing Approach for Direct Haplotype Phasing in Clinical Settings
title_full_unstemmed A Long-Read Sequencing Approach for Direct Haplotype Phasing in Clinical Settings
title_short A Long-Read Sequencing Approach for Direct Haplotype Phasing in Clinical Settings
title_sort long read sequencing approach for direct haplotype phasing in clinical settings
topic nanopore sequencing
variant calling
haplotype phasing
diagnostic testing
url https://www.mdpi.com/1422-0067/21/23/9177
work_keys_str_mv AT simonemaestri alongreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT mariagiovannamaturo alongreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT emanuelacosentino alongreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT lucamarcolungo alongreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT barbaraiadarola alongreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT elisabettafortunati alongreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT marziarossato alongreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT massimodelledonne alongreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT simonemaestri longreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT mariagiovannamaturo longreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT emanuelacosentino longreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT lucamarcolungo longreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT barbaraiadarola longreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT elisabettafortunati longreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT marziarossato longreadsequencingapproachfordirecthaplotypephasinginclinicalsettings
AT massimodelledonne longreadsequencingapproachfordirecthaplotypephasinginclinicalsettings